The Sox2–Hippo axis has been shown to directly inhibit Neurofibromatosis Type 2 (NF2) protein and activate YAP, driving cell plasticity in both osteosarcoma and GBM cell lines [27]. The gene discussed is SOX2; the disease is glioblastoma.